AIFF (Firefly Neuroscience) EBIT: $-8.91 Mil (TTM As of Mar. 2026)


AIFF Firefly Neuroscience Inc AIFF
9 GF Score
Price $1.26
! 4 Warning Signs
View Full Analysis

What is Firefly Neuroscience EBIT?

Firefly Neuroscience AIFF +5.04% 9 EBIT is $-8.91 Mil as of Mar. 2026. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review.

Firefly Neuroscience's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-2.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.91 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Firefly Neuroscience's annualized ROC % for the quarter that ended in Mar. 2026 was -116.53%. Firefly Neuroscience's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -4,657.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Firefly Neuroscience's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -48.06%.

Firefly Neuroscience  (NAS:AIFF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Firefly Neuroscience's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-8.04 * ( 1 - 0% )/( (7.156 + 6.643)/ 2 )
=-8.04/6.8995
=-116.53 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10.477 - 2.113 - ( 2.747 - max(0, 2.819 - 4.027+2.747))
=7.156

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10.91 - 2.26 - ( 3.127 - max(0, 2.454 - 4.461+3.127))
=6.643

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Firefly Neuroscience's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-7.988/( ( (0.146 + max(-1.539, 0)) + (0.197 + max(-1.18, 0)) )/ 2 )
=-7.988/( ( 0.146 + 0.197 )/ 2 )
=-7.988/0.1715
=-4,657.73 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.194 + 0.108 + 0.978) - (2.113 + 0.228 + 0.478)
=-1.539

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.129 + 0.103 + 1.042) - (2.26 + 0.194 + 4.4408920985006E-16)
=-1.18

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Firefly Neuroscience's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-8.913/18.547
=-48.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Firefly Neuroscience EBIT Related Terms

Firefly Neuroscience EBIT Historical Data

* Premium members only.

The historical data trend for Firefly Neuroscience's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Firefly Neuroscience EBIT Chart

Firefly Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
-4.25 -3.22 -2.58 -10.39 -19.72

Firefly Neuroscience Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.80 -1.81 -2.63 -2.47 -2.00

AIFF vs LPSN, AVAI, ANKM: EBIT Comparison

For the Software - Application subindustry, Firefly Neuroscience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firefly Neuroscience EV-to-EBIT vs Software Industry

For the Software industry and Technology sector, Firefly Neuroscience's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Firefly Neuroscience's EV-to-EBIT falls into.


AIFF
9GF Score
Firefly Neuroscience Inc AIFF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Firefly Neuroscience EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-8.91 Mil mean?
Firefly Neuroscience (AIFF) has a EBIT of $-8.91 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Firefly Neuroscience.
Is Firefly Neuroscience's EBIT too high?
Firefly Neuroscience's current EBIT is $-8.91 Mil. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's EBIT compare to LPSN and AVAI?
Firefly Neuroscience's EBIT of $-8.91 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Software company?
A good EBIT depends on the Software industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Firefly Neuroscience. Firefly Neuroscience's current EBIT is $-8.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current EBIT of $-8.91 Mil. The current EBIT is $-8.91 Mil. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current EBIT is $-8.91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Firefly Neuroscience Business Description

Address 1100 Military Road, Kenmore, NY, USA, 14217
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score

Get the complete analysis for AIFF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.26
Price